MLL4 is a critical mediator of differentiation and ferroptosis in the epidermis

Shaun Egolf,Jonathan Zou,Amy Anderson,Yann Aubert,Kai Ge,John T. Seykora,Brian C. Capell
DOI: https://doi.org/10.1101/2021.05.03.442432
2021-05-04
Abstract:ABSTRACT The epigenetic regulator, MLL4 ( KMT2D ), has been described as an essential gene in both humans and mice 1,2 . In addition, it is one of the most commonly mutated genes in all of cancer biology 3–7 . Here, we identify a critical role for Mll4 in the promotion of epidermal differentiation and ferroptosis, a key mechanism of tumor suppression 8,9 . Mice lacking epidermal Mll4 , but not the related enzyme Mll3 ( Kmt2c ), display features of impaired differentiation and human pre-cancerous neoplasms, including epidermal hyperplasia, atypical keratinocytes, and a loss of polarization, all of which progress with age. Mll4 deficiency profoundly alters epidermal gene expression, and uniquely rewires the expression of key genes and markers of ferroptosis ( Alox12 , Alox12b , Aloxe3 ) 10 . Beyond identifying a novel role for Mll4 -mediated tumor suppression in the skin, our data reveal a potentially much more broad and general role for ferroptosis in the process of epidermal differentiation and skin homeostasis.
What problem does this paper attempt to address?